Persistent URL of this record https://hdl.handle.net/1887/112298
In Collections
This item can be found in the following collections:
![A Randomized, Double-blind, Active-and Placebo-controlled Phase 3 Study of Efficacy and Safety of Ixekizumab, Adalimumab, and Placebo Therapy in Patients Naive to Biologic Disease Modifying Antirheumatic Drugs with Active Psoriatic Arthritis](https://scholarlypublications.universiteitleiden.nl/sites/all/themes/scholarly/img/closed_access.png)
A Randomized, Double-blind, Active-and Placebo-controlled Phase 3 Study of Efficacy and Safety of Ixekizumab, Adalimumab, and Placebo Therapy in Patients Naive to Biologic Disease Modifying Antirheumatic Drugs with Active Psoriatic Arthritis
- All authors
- Mease, P.; Heijde, D. van der; Ritchlin, C.; Cuchacovich, R.; Shuler, C.; Lin, C.Y.; Vangerow, H.; Samanta, S.; Lee, C.; Gladman, D.
- Date
- 2016-06-30
- Journal
- Journal of Rheumatology
- Volume
- 43
- Issue
- 6
- Pages
- 1169 - 1169